Interactions of the oxygen-dependent antimicrobial system of the human neutrophil with difloxacin, ciprofloxacin, pefloxacin and fleroxacin in the intraphagocytic eradication of Staphylococcus aureus

References

1. Anderson R, Joone G, van Rensburg C E J. 1986; An in vitro investigation of the intracellular bioactivity of amoxicillin, clindamycin and erythromycin for Staphylococcus aureus. Journal of Infectious Diseases 153:593–600
   [Google Scholar]
2. Anderson R, van Rensburg C E J, Joone G, Lukey P T. 1987; An in-vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin. Journal of Antimicrobial Chemotherapy 20:Suppl B57–68
   [Google Scholar]
3. Curnutte J T, Whitten D M, Babior B M. 1974; Defective superoxide production by granulocytes from patients with chronic granulomatous disease. New England Journal of Medicine 290:593–597
   [Google Scholar]
4. Eggleston M, Park S Y. 1987; Review of the 4-quinolones. Infection Control 8:119–125
   [Google Scholar]
5. Van Rensburg C E J, Joone G, Anderson R. 1989; An in vitro investigation of the intraphagocytic bioactivity of difloxacin, ciprofloxacin, pefloxacin and fleroxacin. International Journal of Chemotherapy 35:273–277
   [Google Scholar]
6. Vosbeck K, James P R, Zimmermann W. 1984; Antibiotic action on phagocytosed bacteria measured by a new method for determining viable bacteria. Antimicrobial Agents and Chemotherapy 25:735–741
   [Google Scholar]